Doctors typically recommend staying on the current dose for 6 weeks to determine if any issues develop before increasing the dose
Recently, the Judicial Panel on Multidistrict Litigation (JPML) was asked to add two injuries to the complaintdeep vein thrombosis (blood clots) and NAION (permanent vision loss from eye strokes)
D.PerdueL
FOXO4-DRI vs nearby senolytics Option FOXO4-DRI Type D-retro-inverso peptide Human trial stage None (preclinical only) Option Dasatinib + Quercetin (D+Q) Type Small-molecule drug + flavonoid Human trial stage Early human trials (e.g., Alzheimer's) Option Navitoclax Type BCL-2 family inhibitor Human trial stage Later-stage trials (e.g., myelofibrosis) D+Q and navitoclax are further along in humans but can affect healthy cells (e.g., low platelets)
The answer may depend on the medication, the temperature, the length of exposure, and whether the product was opened or previously used
As this report shows, the quality of API originating from China and used in compounded "semaglutide" in the US cannot be assured and puts patients at serious risk
